Physician profile
Thaiduc Nguyen
NPI 1912092107
$11,605.85
in general payments reported to CMS, 2019-2025
38 companies · $2,382 in 2025
The $2,382 reported for 2025 was more than what 85% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,973 · 2020: $1,463 · 2021: $838 · 2022: $1,092 · 2023: $1,305 · 2024: $2,552 · 2025: $2,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,724 · Travel and Lodging: $1,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,723.62 |
| Travel and Lodging | $1,515.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,468.50 | 2020-2023 | Eterna |
| Relievant Medsystems, INC. | $1,376.64 | 2019-2023 | Intracept |
| Si-Bone, INC. | $1,352.71 | 2024-2025 | |
| Boston Scientific Corporation | $1,270.54 | 2019-2025 | Intracept, Superion Indirect Decompression System, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $1,167.14 | 2024-2025 | Ha Minuteman G3-R, Liberty Si |
| Vertos Medical, INC. | $1,148.23 | 2019-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $473.99 | 2019-2025 | Xtampza, Belbuca |
| Tersera Therapeutics LLC | $457.75 | 2019-2025 | Prialt |
| Abbvie INC. | $427.04 | 2021-2025 | |
| Medtronic, INC. | $405.12 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Stimwave Technologies Incorporated | $323.27 | 2019-2022 | |
| Mml US, INC. | $165.23 | 2025 | Reactiv8 |
| Nevro Corp. | $160.34 | 2019-2023 | Senza |
| Stryker Corporation | $156.21 | 2025 | Multigen 2, Mild Device Kit |
| Amgen INC. | $141.76 | 2019-2023 | Evenity, Prolia |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thaiduc Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.